First-line treatment for locally advanced or metastatic urothelial carcinoma: a randomized controlled phase III study comparing pembrolizumab with and without platinum-based combination chemotherapy and chemotherapy alone in patients with advanced or metastatic urothelial carcinoma (Keynote-361) AB 54/16 of AUO

被引：0
|
作者：
Rexer, H. [1 ]
Ohlmann, C. -H. [2 ]
Retz, M. [3 ]
机构：
[1] AUO Geschaftsstelle, Seestr 11, D-17252 Schwarz, Germany
[2] Arbeitsgemeinschaft Urol Onkol Deutsch Krebsgesel, Organgrp Blasenkarzinom, Kuno Fischer Str 8, D-14057 Berlin, Germany
[3] Tech Univ Munich, Urol Klin & Poliklin, LKP, Klinikum Rdl, Ismaninger Str 22, D-81675 Munich, Germany
来源：
AKTUELLE UROLOGIE | 2018年 / 49卷 / 01期
关键词：
D O I：
10.1055/s-0043-125341
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：21 / 22
页数：2
相关论文
共 50 条
  • [41] Phase 3 study of platinum-based chemotherapy with or without pembrolizumab for first-line metastatic, nonsquamous non-small cell lung carcinoma (NSCLC): KEYNOTE-189.
    Hall, Richard Delmar
    Gadgeel, Shirish M.
    Garon, Edward B.
    Bria, Emilio
    Reck, Martin
    Vida, John
    Zhou, Honghong
    Raftopoulos, Harry
    Gandhi, Leena
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] The Controlling Nutritional Status (CONUT) Score is a Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with First-Line Platinum-Based Chemotherapy
    Suzuki, Hiroaki
    Ito, Masaya
    Takemura, Kosuke
    Kobayashi, Shuichiro
    Kataoka, Madoka
    Iida, Noriyuki
    Sekiya, Ken
    Matsumoto, Takuya
    Koga, Fumitaka
    BLADDER CANCER, 2021, 7 (01) : 13 - 21
  • [43] Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study
    Neri, Bruno
    Vannini, Laura
    Giordano, Clara
    Grifoni, Raffaella
    Pantaleo, Pietro
    Baldazzi, Valentina
    Crisci, Alfonso
    Lapini, Alberto
    Raugei, Andrea
    Carini, Marco
    ANTI-CANCER DRUGS, 2007, 18 (10) : 1207 - 1211
  • [44] Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
    Necchi, Andrea
    Sonpavde, Guru
    Lo Vullo, Salvatore
    Giardiello, Daniele
    Bamias, Aristotelis
    Crabb, Simon J.
    Harshman, Lauren C.
    Bellmunt, Joaquim
    De Giorgi, Ugo
    Sternberg, Cora N.
    Cerbone, Linda
    Ladoire, Sylvain
    Wong, Yu-Ning
    Yu, Evan Y.
    Chowdhury, Simon
    Niegisch, Gunter
    Srinivas, Sandy
    Vaishampayan, Ulka N.
    Pal, Sumanta K.
    Agarwal, Neeraj
    Alva, Ajjai
    Baniel, Jack
    Golshayan, Ali-Reza
    Morales-Barrera, Rafael
    Bowles, Daniel W.
    Milowsky, Matthew I.
    Theodore, Christine
    Berthold, Dominik R.
    Daugaard, Gedske
    Sridhar, Srikala S.
    Powles, Thomas
    Rosenberg, Jonathan E.
    Galsky, Matthew D.
    Mariani, Luigi
    EUROPEAN UROLOGY, 2017, 71 (02) : 281 - 289
  • [45] Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
    Rosenberg, Jonathan E.
    Hoffman-Censits, Jean
    Powles, Tom
    van der Heijden, Michiel S.
    Balar, Arjun V.
    Necchi, Andrea
    Dawson, Nancy
    O'Donnell, Peter H.
    Balmanoukian, Ani
    Loriot, Yohann
    Srinivas, Sandy
    Retz, Margitta M.
    Grivas, Petros
    Joseph, Richard W.
    Galsky, Matthew D.
    Fleming, Mark T.
    Petrylak, Daniel P.
    Perez-Gracia, Jose Luis
    Burris, Howard A.
    Castellano, Daniel
    Canil, Christina
    Bellmunt, Joaquim
    Bajorin, Dean
    Nickles, Dorothee
    Bourgon, Richard
    Frampton, Garrett M.
    Cui, Na
    Mariathasan, Sanjeev
    Abidoye, Oyewale
    Fine, Gregg D.
    Dreicer, Robert
    LANCET, 2016, 387 (10031): : 1909 - 1920
  • [46] KEYNOTE-826: A phase III randomized study of chemotherapy with or without pembrolizumab for first-line treatment of persistent, recurrent, or metastatic cervical cancer
    Fujiwara, K.
    Shapira-Frommer, R.
    Alexandre, J.
    Monk, B.
    Fehm, T.
    Colombo, N.
    Caceres, M. V.
    Hasegawa, K.
    Dubot, C.
    Li, J. J.
    Stein, K.
    Keefe, S. M.
    Tewari, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [47] PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma
    Zhang, Xuanye
    Zhou, Yixin
    Chen, Hualin
    Chen, Chen
    Lin, Zuan
    He, Li-na
    Du, Wei
    Chen, Tao
    Hong, Shaodong
    Fu, Sha
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Impact of paclitaxel, cisplatin, and gemcitabine as first-line chemotherapy in cisplatin-fit and -unfit patients with advanced/metastatic urothelial carcinoma
    Katayama, Satoshi
    Kobayashi, Yasuyuki
    Takamoto, Atsushi
    Edamura, Kohei
    Sadahira, Takuya
    Iwata, Takehiro
    Nishimura, Shingo
    Sako, Tomoko
    Wada, Koichiro
    Araki, Motoo
    Watanabe, Masami
    Watanabe, Toyohiko
    Nasu, Yasutomo
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 731.e25 - 731.e32
  • [49] First-line Treatment for locally advanced or metastatic Urothelial Carcinoma: A randomized, double-blind Phase-III-Multicenter Study of adjuvant Nivolumab Therapy versus Placebo in Patients with invasive High-Risk Urothelial Carcinoma
    Rexer, H.
    Ohlmann, C. -H.
    Gschwend, J.
    AKTUELLE UROLOGIE, 2018, 49 (04) : 308 - 309
  • [50] Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma
    Teo, Min Yuen
    Mota, Jose Mauricio
    Whiting, Karissa A.
    Li, Han A.
    Funt, Samuel A.
    Lee, Chung-Han
    Solit, David B.
    Al-Ahmadie, Hikmat
    Milowsky, Matthew, I
    Balar, Arjun, V
    Pietzak, Eugene
    Dalbagni, Guido
    Bochner, Bernard H.
    Ostrovnaya, Irina
    Bajorin, Dean F.
    Rosenberg, Jonathan E.
    Iyer, Gopa
    EUROPEAN UROLOGY, 2020, 78 (06) : 907 - 915
12345